STMN1 and pancreatic neuroendocrine neoplasm: Knockdown of stathmin results in a decrease in cellular proliferation and invasion in lung cancer cells [3] and in pancreatic neuroendocrine neoplasm cells, and PI3 K inhibitors directly inhibits proliferation via stathmin inactivation [28].